CRISPR/Cpf1 system is a novel genomic editing tool. Because of its more sophisticated components, and lower off-target rate, it has the potential to become a better gene-editing tool. Previous reports showed that CRISPR/Cpf1 could work effectively in multiple species. But our data show that AsCpf1 activity has a big difference in different vertebrates. Using in vitro experiments, we finally learned that the difference between species is due to temperature.
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In recent years, gene-editing tools have been greatly developed, and are widely used.
CRISPR/Cpf1 system is a new member of the gene-editing technique family, and current researches have shown its better ease of use (Jiang et al., 2017; Kim et al., 2016b; Port and Bullock, 2016; Tang et al., 2017; Zetsche et al., 2015) . This system can target and cut specific double-stranded DNA (dsDNA) with only two elements:
CRISPR RNA (crRNA) and Cpf1 protein. CRISPR RNA recognizes and targets specific DNA sequence, and guides Cpf1 protein to assemble a ternary complex; ultimately, Cpf1 protein cut the targeted dsDNA. Cpf1 protein is smaller than Cas9, and crRNA, only 43nt(including 23nt recognition sequence), is also shorter than sgRNA. Based on reports, Cpf1 has outstanding performance in the off-target profile (Kim et al., 2016a; Kleinstiver et al., 2016) . These advantages have shown this system is potentially better than ever before gene-editing tools. From plants to animals, CRISPR/Cpf1 has been validated in multiple species (Kim et al., 2016b; Port and Bullock, 2016; Tang et al., 2017; Toth et al., 2016; Zetsche et al., 2015) , but some commonly used laboratory animal models have been reported rarely. Thus, we want to test the CRISPR/Cpf1 system on embryos of four commonly used model animals:
Verified the effectiveness of AsCpf1 in a variety of species 5 mice, porcine (female embryos), frogs(Xenopus), zebrafish; in this study, we have chosen AsCpf1, because of its significant functionality of cutting dsDNA (Kim et al., 2016a; Kim et al., 2016b; Kleinstiver et al., 2016; Zetsche et al., 2015) , as testing subject on embryos of these four commonly used models.
In the mouse genome, we chose mTet2 locus as target gene loci, and selected four targets for this locus. Validated CRISPR/Cas9 target in mTet2 was used as positive control (Wang et al., 2013) . In order to obtain more reliable results in mouse embryos, we first assessed the effectiveness of selected target sites in mouse embryonic stem cells (mESCs) (Supplementary Figure 1a, b) . We transfected PiggyBac plasmids that contain AsCpf1 gene and puromycin resistance gene into mESCs. After puromycin selection, transgenic cells stably expressed AsCpf1 proteins. Then, the crRNAs were transfected into transgenic cells. 48 hours after transfection, cells were collected to do double strand DNA breaks (DSB) assay. The results show all mTet2 targets were cut (Supplementary Figure 1c, d) , and the highest cleavage efficiency is crmTet2-1, 50% (Supplementary Figure 1c, Supplementary Table 1) ; sgRNA cleavage efficiency at the same gene locus is 95% (Supplementary Figure 1c, d ).
After screening, we chose crmTet2-1 as target for testing CRISPR/Cpf1 system in mouse embryos.
We optimized the nuclear localization signal (NLS) prior to the mouse experiment (Supplementary Figure 1e) , and found that the addition of NLS at the N-terminus of AsCpf1 did not significantly alter the function of AsCpf1 (Supplementary Figure 1f, g). So in the follow-up experiments we only add NLS to the C-terminus.
Referring CRISPR/Cas9 mouse embryo operating standard (Wang et al., 2013) , 50ng/ul AsCpf1 mRNA and 20ng/ul crRNA were used. Injected embryos were cultured to the blastocyst stage, and were collected to prepare genome. After Sanger sequencing, we found that crmTet2-1 target site has been cut and had indel (efficiency: 32%) (Fig a, Supplementary Figure 2a, Supplementary Table 2 ).
In pigs, we have directly operated on parthenogenetic embryos. Four target sites at Verified the effectiveness of AsCpf1 in a variety of species 7 pMSTN locus and two at pSall1 locus have been chosen. Validated CRISPR/Cas9 targets in pMSTN and pSall1 were used as positive control. Referring CRISPR/Cas9 pig parthenogenetic embryo operating standard (Zhou et al., 2015) , 200ng/ul Cpf1 mRNA and 20ng/ul crRNA were used. Two target sites of pMSTN have occurred DSB while their cleavage efficiencies are both lower than 20% (Fig b, Supplementary   Figure 2b , c, Supplementary Table 3). Another target site at pSall1 locus also has DSB and it has a little higher cleavage efficiency -33% (Fig c, Supplementary   Figure 
2d, Supplementary Table 4).
In zebrafish and xenopus, we chose two genes for each specie: zUrod, zTyr for zebrafish and xP48, xTyr for xenopus. In addition, four target sites of each gene were designed. Validated CRISPR/Cas9 targets were used as positive control (Guo et al., 2014; Qin et al., 2015) . The data of mRNA injected embryos show no significant occurrence of DSB at these target sites (Supplementary Figure 3a, b, c, d ). There is a suspected difference between control groups and one experimental group (Supplementary Figure 3a) . After Sanger sequencing, those are polymorphism at Verified the effectiveness of AsCpf1 in a variety of species 8 non-target area (data no to show). So, we suspected this result may be because that the number set of targets we detect is too small to be representative of AsCpf1 capacity. So we extended the target sets of these two species, the results show that there is still no DSB present (Supplementary Figure 3e, f, g, h) .
In order to understand whether the target selection or some other issue is the reason of these negative results. We designed an exogenous target detection(ETD) system: cloned the mouse Tet2 Cpf1 target into the vector that expresses GFP, named pTg-mTet2 (Supplementary Figure 4a) , it was co-transfected with AsCpf1 expression plasmid and crRNA into human HEK293T cells. The results showed that exogenous mTet2 target was edited in human cells (Fig d, Supplementary Figure   4b ). After verifying the ETD system can effectively detect the effectiveness of exogenous target, we chose several zebrafish and xenopus targets to test on this system. Surprisingly, it has been found that all those targets are high cleavage efficiency in the HEK293T cells (Fig d, Supplementary Figure 4d) . Since injected mRNAs take a few hours to translate into protein in the embryos, and
AsCpf1 protein is greatly reduced in activity at low temperatures, the strategy of injecting mRNAs is apparently inappropriate. We used crRNAs from those target that had been detected in the ETD system, mixed with AsCpf1 protein and injected into xenopus and zebrafish embryos. By T7E1 DSB assay, there was a slight difference Verified the effectiveness of AsCpf1 in a variety of species 1 0 between the experimental and control groups in each of the two species (Fig f, g ). We
confirmed that there was a single-base mutation in both experimental groups by sanger sequencing (Fig h, i) .
One finer temperature gradient experiment showed that AsCpf1 protein had the highest activity at about 37 Table 7) . We believe that temperature may be the reason why AsCpf1 cut only a small amount of DNA in the two low temperature species -temperature sensitivity.
CRISPR/Cpf1 system has significant advantages in working mechanism. Our data reveal that AsCpf1/crNA system is effective at some target sites in the mammalian embryos. Unfortunately, it did show only a very low-level function in zebrafish and xenopus, which are two classic developmental biology animal models. This may be due to the sensitivity of AsCpf1 to temperature. And prolonged the reaction time under 1 1 low temperature conditions is an effective way (Supplementary Figure 5c) , which can also explain why the low temperature species that have been reported can effectively be genetically modified after obtaining transgenic lines (Port and Bullock, 2016; Tang et al., 2017) . But, it is still unknown that whether to extend the reaction time in non-optimal conditions will increase the risk of off-target? If scientists want to develop CRISPR/Cpf1 system into a mature gene-editing tool, more test and optimization on different species are needed. In this study, we only discussed the effectiveness of the CRISPR/Cpf1 systems in four different animal models, and did not touch the problem of off-target. As a critical evaluation criteria of genome editing tool, off-target of CRISPR/Cpf1 system remains to be further studied.
METHODS

RNA in vitro transcription.
AsCpf1 was synthesized by IGE Biotech Ltd. and cloned into the pCS2+ vector.
AsCpf1 and SpCas9 mRNA were transcribed using the mMessage mMachine SP6 Kit (Thermo Fisher). All crRNAs and sgRNAs were synthesized using the TranscriptAid Verified the effectiveness of AsCpf1 in a variety of species 1 2 T7 High Yield Transcription Kit (Thermo Fisher). ssDNA oligos (Supplemental Material) corresponding to the reverse complement of the target sequence were synthesized from Thermo Fisher Scientific Inc and IDT, and annealed to a short T7 primer. All
RNAs were purified using the ZR-96 RNA Clean Kit (Zymo). Cpf1/Cas9 mRNA and 50ng/uL crRNA/sgRNA) was injected into the cytoplasm of fertilized eggs with well recognized pronuclei in M2 medium (Millipore). The injected zygotes were cultured in G1/G2 medium (Vitrolife) at 37 o C under 6% CO 2 in air until blastocyst stage by 3.5 days.
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Pig oocyte/embryos acquisition, activation, RNAs microinjection, and culture.
Briefly, pig ovaries were collected from a local slaughterhouse and transported to the laboratory in 0.9% saline with penicillin and streptomycin at 35 °C to 39 °C. Cumulus oocyte complexes(COCs) were aspirated from antral follicles using 10ml syringe. mRNA and 20ng/uL crRNA/sgRNA and ddH 2 O as control. The injected embryos were cultured in PZM3 for 6 days and the blastocysts were collected for analysis.
Zebrafish embryos microinjection and culture.
Wild type Tu line embryos were raised at 28.5℃. One-cell stage zebrafish embryos were injected with 2 nL of a solution containing 200 ng/μL Cpf1/Cas9 mRNA/protein and 20 ng/μL crRNA/sgRNA. For exogenous targets test, injection solution was included 10 pg/uL pTg-mTet2 plasmid. The injected embryos were cultured in 1x E3 mediumv (5.0 mM NaCl, 0.17mM KCl, 0.33mM CaCl, 0.33mM MgSO 4 , pH 7.4) for 2 days, and then were collected for analysis.
Xenopus embryos microinjection and culture.
One-cell stage xenopus embryos were injected with 2 nL of a solution containing 300ng/μL Cpf1/Cas9 mRNA/protein and 100ng/μL crRNA/sgRNA. For exogenous targets test, injection solution was included 10 pg/uL pTg-mTet2 plasmid. The injected embryos were cultured in 0.1x MBS medium (1x MAS: 88 mM NaCl, 2.4 mM NaHCO 3 , 1 mM KCl, 0.82mM MgSO 4 , 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 10 mM HEPES pH 7.4) for 24 hours, and then were collected for analysis.
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Genomic DNA was extracted using the QuickExtract DNA Extraction Solution (Epicentre) following the manufacturer's instruction. Genomic region surrounding the target sites for each gene was PCR amplified. Half PCR products were used for T7 Endonuclease I assay: 10uL PCR products were mixed with 2uL NEB buffer 2 and ddH20 to a final volume of 20uL, and subjected to a re-annealing process to enable heteroduplex formation: 95ºC for 10min, 95ºC to 85ºC ramping at -2ºC/s, 85ºC to 25ºC at -0.2ºC/s, and 25ºC hold for 1 minute. After re-annealing, products were treated with T7 Endonuclease I (NEB) at 37 ºC for 30min, and analyzed on 10% TBE poly-acrylamide gels. Gels were stained with SYBR Gold DNA stain (Thermo Fisher) for 30 minutes and imaged with Tanon 1600 digital gel image analysis system (Tanon).
The remaining PCR products were gel extraction, cloned into pMD18T (Takara) vector, and sequenced for counting indels.
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